CENTRO DI DOCUMENTAZIONE SUI DISPOSITIVI MEDICI

From Web site Written by  Catharine Paddock PhD Published:  Thursday 19 January 2017 Scientists have developed a dental implant containing a reservoir for the slow release of drugs. Laboratory tests in which the reservoir slowly released a strong antimicrobial agent showed that the new implant can prevent and eliminate bacterial biofilms - a major cause of infection associated with dental implants. The researchers, from various departments at KU Leuven in Belgium, describe how they designed and tested the implant in a paper published in the journal   European Cells & Materials . Lead author Dr. Kaat De Cremer, from the Centre of Microbial and Plant Genetics at KU Leuven, explains that the reservoir in the implant can be filled by removing the cover screw.  She adds that: "The implant is made of a porous composite material, so that the drugs gradually diffuse from the reservoir to the outside of the implant, which is in direct contact wi...

Luca Martinelli Publication 25th November 2016 1.FOREWORD It’s appropriate to underline that as of today (25.11.2016) the Official Journal has not published yet the new regulation. This fact doesn’t prevent to make some considerations about some new features in the final draft. The new Regulation of the European Parliament of the Council on medical devices, amending Directive 2001/83/CE, Regulation (CE) nr. 178/2002 and Regulation (CE) nr. 1223/2009 will replace Directives 90/385/CEE “on the approximation of the States member relating the active implantable medical devices” and 93/42/CEE “on medical devices”, establishes the figure of the “ person responsible for regulatory compliance ”. 2.PERSON RESPONSIBLE FOR REGULATORY COMPLIANCE 2.1 Who is him? The new Regulation requires that the manufacturer must ensure that the supervision and control of medical devices manufacturing, as well as the supervisory and post-market surveillance activities related to them, ...

Quasar Dental Equipment presenta GREENBRUSH , il nuovo strumento da laboratorio per modellazione. Quasar Dental Equipment presents GREENBRUSH , the new carver laboratory instrument. GREENBRUSH è composto da un manico in resina atossica e acciaio INOX sul quale si possono applicare a proprio piacimento una delle sei punte più utilizzate per la modellazione di ceramica, composito ecc. insieme a un pennellino monouso. GREENBRUSH is made with an atoxic resin handle and stanley Steel where you can put one of the six tips used for carving ceramic, composite and so on, together with a disposable brush.                    GREENBRUSH GREENBRUSH si aggiunge al già noto REDTIP strumento per modellazione che permette di inserire le punte su entrambi i lati. GREENBRUSH is added to REDTIP already known instrument for carving which permits to insert the tips on both sides.  REDTIP

L'impiego in campo medico-chirurgico dei Google glass è già noto ma l a prima applicazione al mondo per il settore dentistico per i Google glass è nata in Italia. I Google glass per dentisti si chiamano  “Dental Class”. Gherò, noto distributore e fabbricante OBL italiano di dispositivi medici per odontoiatria, e Sell Well, agenzia italiana di marketing che si occupa di strategie di di consulting, conception, creativity, communication e controlling, hanno sviluppato il primo software per dentisti aplicato ai Google Glass. Grazie a questa applicazione il dentista potrà ottimizzare i tempi e migliorare le prestazioni sul paziente avendo continuamente a disposizioni le informazioni su di esso. Le nuove informazioni acquisite sul paziente possono essere digitalizzate in tempo reale. I Dental Class si indossano durante il lavoro sul paziente. Il minicomputer, posizionato sulla stanghetta destra dei Google Glass, si collega direttamente al software sul pc dello...

From Website Posted 32 January 2017 By  Zachary Brennan "In a sign of what’s to come for the US Food and Drug Administration (FDA), President Donald Trump told pharmaceutical company CEOs Tuesday that his administration will be “cutting regulations at a level no one has ever seen before.” The comments, which came before the meeting with CEOs from industry group PhRMA, Merck, Novartis, Johnson & Johnson, Celgene and others, Trump said in terms of the drug approval process: “We’re also going to be streamlining the process, so that from your standpoint, when you have a drug you can actually get it approved, instead of waiting for many, many years." He also called for significantly lower drug prices and  again  for better negotiations on drug prices between Medicare and companies. “We’re going to get the approval process much faster,” he repeated, noting that “one thing that’s always disturbed me is that you come up with a new drug for a pa...

From Web site Published:  Monday 30 January 2017  "The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products. In light of these findings, the FDA contacted Standard Homeopathic Company in Los Angeles, the manufacturer of Hyland's homeopathic teething products, regarding a recall of its homeopathic teething tablet products labeled as containing belladonna, in order to protect consumers from inconsistent levels of belladonna. At this time, the company has not agreed to conduct a recall. The FDA recommends that consumers stop using these products marketed by Hyland's immediately and dispose of any in th...

The Rapid Alert System for non-food dangerous products facilitates the rapid exchange of information between   national authorities   of 31 countries and the European Commission on dangerous products found on the market. The Commission publishes a weekly overview of the alerts on products reported by the national authorities. They include information on the dangerous products found, the risks identified and the measures taken in the notifying country in order to prevent or restrict their marketing or use. Measures can be ordered by national authorities ("compulsory measures") or be taken directly by producers and distributors ("voluntary measures"). Each alert also includes information on the countries where the same product was found and further measures were taken. Updated to / Aggiornamento al  10/02/2017 Rapid Alert System – Weekly Notification reports LINK> REPORT RAPEX

Dal 21 al 27 giugno 2017 al Gazzetta Summer Camp di Canazei la scrittrice Annalisa Strada, l’attore Paolo Zambon e l’illustratore Fausto Bianchi insegneranno a bambini e ragazzi a scrivere e mettere in scena una storia. Canazei (Val di Fassa), 21-27 giugno 2017- Sports Promotion promuove l’arte del teatro, dell’illustrazione e della scrittura ai giovani che parteciperanno al Gazzetta Summer Camp. Incoraggiati a scrivere una storia da Annalisa Strada, scrittrice, insegnante, consulente editoriale; a rappresentarla insieme all’attore Paolo Zambon, attore, regista, insegnante di teatro per bambini e ragazzi, autore del format contro il bullismo “Educare al rispetto come antidoto alla violenza”; a illustrarla con l’aiuto di Fausto Bianchi illustratore, pittore e insegnante di disegno i ragazzi che parteciperanno al Camp Scrittura e Teatro vivranno una settimana magica. Una proposta formativa unica nel suo genere che unisce parole, immagini, fantasia, risate e sport per scop...

From Web site By  Kerry Sheridan A p ilot study in San Francisco has shown that virtual reality (VR) can help children and teens escape from the pain of sickle cell disease, and future studies are planned to ease discomfort for youths being treated for cancer. The idea came from video game developer Simon Robertson, who also happened to be a volunteer at the   University of California San Francisco Benioff Children’s Hospital   in Oakland. Decreasing the Pain Felt Robertson said he had read about pioneering research led by Hunter Hoffman at the University of Washington in 2000, showing that VR helped decrease the pain felt by adolescent burn patients as they had their wounds dressed. “I remember reading that and thinking, ‘Oh, that is fantastic that they do that,’” said Robertson. “I just assumed they did that in every hospital now because this research is really convincing. But I was disappointed to discover that they were not doing it at my local ...